Recombinant hepatitis B vaccine market is expected to grow at a CAGR of 5.6% during the forecast. The rising incidence of acute and chronic hepatitis B infections across the globe is driving market growth. There is an increased demand for recombinant HBV vaccines 10mcg/ml and 10 mcg/0.5 ml, which provide long-lasting protection against chronic hepatitis B infection. The Hepatitis B vaccine...